Mereo BioPharma Group plc (MREO) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts MREO Hot Sheet
Join SI Premium – FREE
Mereo BioPharma Group plc (NASDAQ: MREO) reported Q2 EPS of ($0.02), $0.01 worse than the analyst estimate of ($0.01).
For earnings history and earnings-related data on Mereo BioPharma Group plc (MREO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA maintains underperform ratings on six BDC stocks
- Myriad Uranium completes acquisition of Rush Rare Metals
- Wolfe Research sees CNH stock flat 2027 outlook on commodity prices
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
